PINK:SGPYY

The Sage Group Stock News

Technology > Software - Application

Buy SGPYY

*Your capital is at risk

$42.52

+0.0600 (+0.141%)

At Close: Jun 23, 2026

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE

10:10pm, Saturday, 17'th Aug 2024

NEW YORK , Aug. 17, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such investors are ad

The Schall Law Firm Is Looking Into Sage Therapeutics Inc. For Securities Violations And Invites Investors With Losses To Join In Conversation

07:45pm, Thursday, 15'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeuti

The Schall Law Firm Is Investigating Sage Therapeutics Inc. For Potential Securities Violations And Encourages Investors Who Have Incurred Losses To Engage In Discussions

08:15pm, Wednesday, 14'th Aug 2024

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or "the Company") (NASDAQ:SAGE)

The Schall Law Firm Is Investigating Sage Therapeutics Inc. For Potential Securities Violations And Urges Investors Who Have Incurred Losses To Initiate Discussions

11:30pm, Tuesday, 13'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeuti

The Schall Law Firm Is Investigating Sage Therapeutics Inc. For Potential Securities Violations And Encourages Investors Who Have Incurred Losses To Initiate Discussions

08:45pm, Monday, 12'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeuti

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE

10:00am, Sunday, 11'th Aug 2024

NEW YORK, NY / ACCESSWIRE / August 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ:SAGE). Such investors are advise

Sage Therapeutics Inc Is Under The Schall Law Firm's Probe For Possible Securities Breaches And Investors With Losses Are Encouraged To Begin Conversations

07:00pm, Friday, 09'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutic

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE

11:45am, Friday, 09'th Aug 2024

NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such investors are advised to c

Sage Therapeutics Inc Is Being Investigated By The Schall Law Firm For Potential Securities Violations And Investors With Losses Are Urged To Initiate Dialogue

07:45pm, Thursday, 08'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutic

Sage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE

10:00am, Thursday, 08'th Aug 2024

LOS ANGELES, Aug. 8, 2024 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Sage Therapeutics, Inc. ("Sage" or "the Company") (NASDAQ: SAGE) for violations of §�

Sage Therapeutics Inc Is Under Investigation By The Schall Law Firm For Potential Securities Violations, And Investors With Losses Are Encouraged To Initiate Dialogue

06:30pm, Wednesday, 07'th Aug 2024

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or "the Company") (NASDAQ:SAGE)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE

01:00pm, Wednesday, 07'th Aug 2024

NEW YORK, NY / ACCESSWIRE / August 7, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ:SAGE). Such investors are advised

Sage Therapeutics Inc Investigated By The Schall Law Firm For Possible Securities Violations Investors With Losses Urged To Engage In Dialogue

05:30pm, Tuesday, 06'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutic

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE

02:26pm, Saturday, 03'rd Aug 2024

NEW YORK, Aug. 03, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE). Such investors ar

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE

05:10pm, Thursday, 01'st Aug 2024

NEW YORK , Aug. 1, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such investors are advised to

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by